Holen Sie sich die Stockscreener-App
9.98
1.73%
0.17
Handel nachbörslich:
9.99
0.010
+0.10%
Schlusskurs vom Vortag:
$9.81
Offen:
$9.84
24-Stunden-Volumen:
21,884
Relative Volume:
0.54
Marktkapitalisierung:
$159.65M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-33.82M
KGV:
-0.39
EPS:
-25.5891
Netto-Cashflow:
$-66.04M
1W Leistung:
+0.91%
1M Leistung:
+29.27%
6M Leistung:
+7.20%
1J Leistung:
+96.46%
1-Tages-Spanne:
$9.20
$9.99
1-Wochen-Bereich:
$9.20
$10.75
52-Wochen-Spanne:
$3.70
$10.75
Elicio Therapeutics Inc Stock (ELTX) Company Profile
Firmenname
Elicio Therapeutics Inc
Sektor
Branche
Telefon
(857) 209-0050
Adresse
451 D STREET, 5TH FLOOR, BOSTON
Vergleichen Sie ELTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELTX
Elicio Therapeutics Inc
|
9.98 | 156.93M | 0 | -33.82M | -66.04M | -25.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Elicio Therapeutics Inc Aktie (ELTX) Neueste Nachrichten
What analysts say about Elicio Therapeutics Inc. stockMarket-beating returns - jammulinksnews.com
Is Elicio Therapeutics Inc. a good long term investmentGame-changing returns - jammulinksnews.com
How does Elicio Therapeutics Inc. generate profit in a changing economyBuild wealth with high-performing stocks - jammulinksnews.com
How volatile is Elicio Therapeutics Inc. stock compared to the marketNavigate market shifts with confidence - jammulinksnews.com
Should I hold or sell Elicio Therapeutics Inc. stock in 2025Invest confidently with real-time updates - jammulinksnews.com
Visual trend scoring systems applied to Elicio Therapeutics Inc.Long Hold Investment Strategy with Growth Focus - newser.com
What are analysts’ price targets for Elicio Therapeutics Inc. in the next 12 monthsMaximize gains with data-driven stock picks - jammulinksnews.com
Can trapped investors hope for a rebound in Elicio Therapeutics Inc.Safe Entry Zone Based on Chart Analysis - Newser
What institutional investors are buying Elicio Therapeutics Inc. stockGet daily updates on market movers and shakers - jammulinksnews.com
Intraday pattern recognizer results for Elicio Therapeutics Inc.Quarterly Investment Outlook and Key Summary - newser.com
What makes Elicio Therapeutics Inc. stock price move sharplyRisk Aware Trading Ideas with Alert Levels - newser.com
What catalysts could drive Elicio Therapeutics Inc. stock higher in 2025Invest in stocks with strong fundamentals - jammulinksnews.com
What is the risk reward ratio of investing in Elicio Therapeutics Inc. stockSkyrocketing returns - jammulinksnews.com
Elicio Therapeutics secures $10 million in direct offering - MSN
Is Elicio Therapeutics Inc. trending in predictive chart modelsFree Swing Trading Plan With Smart Signals - Newser
Predicting Elicio Therapeutics Inc. trend using moving averagesFree Value Investing Picks With Stability - Newser
Is Elicio Therapeutics Inc. Stock Overbought or Oversold RSI Indicator AnalysisMachine Learning Stock Price Forecast Tool - newser.com
How hedge fund analytics apply to Elicio Therapeutics Inc. stockSteady Return Plan Based on Data Analysis - Newser
Is Elicio Therapeutics Inc. Stock a Good Fit for Conservative InvestorsSector Rotation Strategy for Smart Traders - Newser
Why is Elicio Therapeutics Inc. stock attracting strong analyst attentionStock Market Ideas With Proven Results - jammulinksnews.com
How Elicio Therapeutics Inc. stock performs during market volatilityMarket Timing Strategy with Technical Filters - Newser
Elicio Therapeutics Inc. Forms Bullish Flag — Upside AheadStep-by-Step Stock Investment Guide Gains Popularity - metal.it
What are Elicio Therapeutics Inc. company’s key revenue driversStock Strategy Picks For 2025 - jammulinksnews.com
Market reaction to Elicio Therapeutics Inc.’s recent newsFree Low Risk Buy Zone Opportunity Watch - Newser
Applying chart zones and confluence areas to Elicio Therapeutics Inc.Free Wealth Building Stock Market Ideas - Newser
Elicio Therapeutics Inc. recovery potential after sell offFree Trade Scanner With Buy Zone Alerts - Newser
Elicio Therapeutics Announces $10.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - The Globe and Mail
Analyzing recovery setups for Elicio Therapeutics Inc. investorsDaily Pick Forecast with Entry Zones - Newser
Analyzing Elicio Therapeutics Inc. with multi timeframe chartsMulti-Bagger Detection with Trend Tools - Newser
Developing predictive dashboards with Elicio Therapeutics Inc. dataSummary of Consistent Growth Stock Picks - Newser
Why Elicio Therapeutics Inc. stock attracts strong analyst attentionRisk-Managed Trade Alerts for Consistency - newser.com
Unlocking Oncology’s Future: 3 Trending Cancer Biotech Stocks With ‘Strong Buy’ Ratings - Barchart.com
Published on: 2025-07-28 18:37:53 - metal.it
How strong is Elicio Therapeutics Inc. company’s balance sheetExponential wealth increase - jammulinksnews.com
Trapped Investors in Elicio Therapeutics Inc. Await Breakout SignalInvestment Plan With Growth Optimization Finalized - metal.it
Finanzdaten der Elicio Therapeutics Inc-Aktie (ELTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):